http://www.relsys.net Relsys - Drug Safety, Pharmacovigilance and Risk Management Solutions en-us http://feedproxy.google.com/~r/relsys/~3/yu0mI-drP2Q/018053_EN Oracle today announced that it has agreed to acquire Relsys, a leading provider of drug safety and risk management solutions with advanced analytics for the health sciences industry.<img src="http://feeds.feedburner.com/~r/relsys/~4/yu0mI-drP2Q" height="1" width="1"/> http://www.oracle.com/us/corporate/press/018053_EN http://feedproxy.google.com/~r/relsys/~3/On_G0oqYbVo/09-03-16.asp Relsys International announces the release of the Argus Safety Suite 5.0, the new standard in global Drug Safety and Risk Management systems.<img src="http://feeds.feedburner.com/~r/relsys/~4/On_G0oqYbVo" height="1" width="1"/> http://www.relsys.net/about_relsys/news/09-03-16.asp http://feedproxy.google.com/~r/relsys/~3/U-V685U6AZI/08-12-05.asp Relsys International launches the pharmacovigilance Integrated Service Offering and significantly expands project delivery capabilities<img src="http://feeds.feedburner.com/~r/relsys/~4/U-V685U6AZI" height="1" width="1"/> http://www.relsys.net/about_relsys/news/08-12-05.asp http://feedproxy.google.com/~r/relsys/~3/1yJQrsfgPsk/PartnersinSafety_08i5.pdf In this issue, Chris discusses how Relsys' Global Professional Services will continue to develop itself into a world-class Services organization.<img src="http://feeds.feedburner.com/~r/relsys/~4/1yJQrsfgPsk" height="1" width="1"/> http://www.relsys.net/about_relsys/resources/PartnersinSafety_08i5.pdf http://feedproxy.google.com/~r/relsys/~3/UpouCF7vCDo/PartnersinSafety_08i4.pdf Partners in Safety Issue 4 includes a discussion of how a service-oriented architecture for Argus can effectively support a pharma's drug safety and risk management activities.<img src="http://feeds.feedburner.com/~r/relsys/~4/UpouCF7vCDo" height="1" width="1"/> http://www.relsys.net/about_relsys/resources/PartnersinSafety_08i4.pdf http://feedproxy.google.com/~r/relsys/~3/B4ugPLwdGlU/C7 This article presents the discussion of how there could be new dynamics that affect life sciences. John Loucks, Chief Customer Officer of Relsys, contributes to this article.<img src="http://feeds.feedburner.com/~r/relsys/~4/B4ugPLwdGlU" height="1" width="1"/> http://www.clinpage.com/article/relsys_beyond_clinical_data/C7 http://feedproxy.google.com/~r/relsys/~3/WeYfg3bIpxU/PartnersinSafety_08i3.pdf The September issue of Partners in Safety discusses Bruce's vision of Argus, Relsys and the industry.<img src="http://feeds.feedburner.com/~r/relsys/~4/WeYfg3bIpxU" height="1" width="1"/> http://www.relsys.net/about_relsys/resources/PartnersinSafety_08i3.pdf http://feedproxy.google.com/~r/relsys/~3/3x75AqFLBHY/C7 In this article, ClinPage discusses the change in the pharma industry's priorities around adverse event reporting.<img src="http://feeds.feedburner.com/~r/relsys/~4/3x75AqFLBHY" height="1" width="1"/> http://www.clinpage.com/article/relsys_on_managing_safety/C7 http://feedproxy.google.com/~r/relsys/~3/g3bLlznF-Vg/PartnersinSafety_08i2.pdf Issue 2 of Partners in Safety provides a foundation for how pharma can move beyond drug safety to patient safety.<img src="http://feeds.feedburner.com/~r/relsys/~4/g3bLlznF-Vg" height="1" width="1"/> http://www.relsys.net/about_relsys/resources/PartnersinSafety_08i2.pdf http://feedproxy.google.com/~r/relsys/~3/LcYPvXOa_TE/08-08-08.asp Relsys International released Service Pack 2 (SP2) of the Argus Safety 4.2 Suite.<img src="http://feeds.feedburner.com/~r/relsys/~4/LcYPvXOa_TE" height="1" width="1"/> http://www.relsys.net/about_relsys/news/08-08-08.asp